Santa Clara, CA, United States of America

Puneet Kumar

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbvie Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Puneet Kumar. Retrieved from https://idiyas.com/inventor/puneet-kumar-bpt16fdg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Puneet Kumar - Innovator in Pharmaceutical Chemistry

Introduction

Puneet Kumar is a notable inventor based in Santa Clara, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds.

Latest Patents

Puneet Kumar holds a patent for Thiazolo[5,4-b]pyridine MALT-1 inhibitors. This patent encompasses compounds of the general Formula (I), which are designed to target specific biological pathways.

Career Highlights

Puneet is currently employed at AbbVie Inc., a leading global biopharmaceutical company. His work focuses on advancing therapeutic solutions that address unmet medical needs.

Collaborations

Puneet has collaborated with esteemed colleagues, including Anthony Mastracchio and Mark Mills. These partnerships have fostered a productive environment for innovation and research.

Conclusion

Puneet Kumar's contributions to pharmaceutical chemistry and his innovative patent work exemplify his commitment to advancing medical science. His collaborations and career at AbbVie Inc. highlight his role as a key player in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…